Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Nature Structural & Molecular Biology|September 19, 2019
Author Correction: Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregationElizabeth L Guenther, Qin Cao, Hamilton Trinh, et al.Proceedings of the National Academy of Sciences of the United States of America|December 18, 2013
Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALSMagdalena I Ivanova, Stuart A Sievers, Elizabeth L Guenther, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 3, 2016
Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3P van de Kerkhof, L Guenther, A B Gottlieb, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 3, 2017
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trialsL Guenther, R B Warren, J C Cather, et al.Brain Sciences|January 24, 2025
Vigorous Exercise Enhances Verbal Fluency Performance in Healthy Young AdultsMaya M Khanna, Corey L Guenther, Joan M Eckerson, et al.Ostomy/Wound Management|March 23, 1999
The role of Apligraf in the treatment of venous leg ulcersK Dolynchuk, P Hull, L Guenther, et al.Proceedings of the National Academy of Sciences of the United States of America|August 2, 2017
Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS)Smriti Sangwan, Anni Zhao, Katrina L Adams, et al.The British Journal of Dermatology|May 11, 2018
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasisC Ryan, A Menter, L Guenther, et al.Nature|September 10, 2015
Structure of the toxic core of α-synuclein from invisible crystalsJose A Rodriguez, Magdalena I Ivanova, Michael R Sawaya, et al.Human Molecular Genetics|November 13, 2013
DNAJC13 mutations in Parkinson diseaseCarles Vilariño-Güell, Alex Rajput, Austen J Milnerwood, et al.Pageof 11